Literature DB >> 17052965

Mild variable Noonan syndrome in a family with a novel PTPN11 mutation.

Martin Zenker1, Egbert Voss, André Reis.   

Abstract

Noonan syndrome (OMIM 163950) is a common genetic condition with variable clinical expression and genetic heterogeneity. About half of the cases can be accounted to activating mutations in the PTPN11 gene encoding SHP-2. We report on a family with mild, variable expression of Noonan syndrome in five individuals. Clinical manifestations included short stature, craniofacial anomalies and thorax deformity, but none of the affected family members had a heart defect. Sequencing of the entire coding region of PTPN11 revealed a novel mutation c.1226G-->C in exon 11 predicting the amino acid exchange G409A. This mutation is not located in the previously known mutation clusters. Our observation and the recent report of a mutation affecting a neighbouring residue (T411M) in a family with a variable phenotype suggest that mutations in this particular region of SHP-2 may have effects on the protein that differ from those of the classical mutations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17052965     DOI: 10.1016/j.ejmg.2006.08.003

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  4 in total

1.  Clinical manifestations in patients with SOS1 mutations range from Noonan syndrome to CFC syndrome.

Authors:  Yoko Narumi; Yoko Aoki; Tetsuya Niihori; Masahiro Sakurai; Hélène Cavé; Alain Verloes; Kimio Nishio; Hirofumi Ohashi; Kenji Kurosawa; Nobuhiko Okamoto; Hiroshi Kawame; Seiji Mizuno; Tatsuro Kondoh; Marie-Claude Addor; Anne Coeslier-Dieux; Catherine Vincent-Delorme; Koichi Tabayashi; Masashi Aoki; Tomoko Kobayashi; Afag Guliyeva; Shigeo Kure; Yoichi Matsubara
Journal:  J Hum Genet       Date:  2008-07-24       Impact factor: 3.172

2.  Diagnosis of Noonan syndrome and related disorders using target next generation sequencing.

Authors:  Francesca Romana Lepri; Rossana Scavelli; Maria Cristina Digilio; Maria Gnazzo; Simona Grotta; Maria Lisa Dentici; Elisa Pisaneschi; Pietro Sirleto; Rossella Capolino; Anwar Baban; Serena Russo; Tiziana Franchin; Adriano Angioni; Bruno Dallapiccola
Journal:  BMC Med Genet       Date:  2014-01-23       Impact factor: 2.103

3.  Heterozygous germline mutations in A2ML1 are associated with a disorder clinically related to Noonan syndrome.

Authors:  Lisenka E L M Vissers; Monica Bonetti; Jeroen Paardekooper Overman; Willy M Nillesen; Suzanna G M Frints; Joep de Ligt; Giuseppe Zampino; Ana Justino; José C Machado; Marga Schepens; Han G Brunner; Joris A Veltman; Hans Scheffer; Piet Gros; José L Costa; Marco Tartaglia; Ineke van der Burgt; Helger G Yntema; Jeroen den Hertog
Journal:  Eur J Hum Genet       Date:  2014-06-18       Impact factor: 4.246

4.  The impact of the genetic background in the Noonan syndrome phenotype induced by K-Ras(V14I).

Authors:  Isabel Hernández-Porras; Beatriz Jiménez-Catalán; Alberto J Schuhmacher; Carmen Guerra
Journal:  Rare Dis       Date:  2015-05-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.